Literature DB >> 2680806

Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.

H Nagata1, K Takahashi, Y Yamane, K Yoshino, T Shibukawa, M Kitao.   

Abstract

Tumor markers have proved to be generally useful for diagnosing and monitoring malignancy. In contrast, high levels of tumor markers disturb us for differing benign disease from malignancy. We had 5 cases with benign disease who showed high values of tumor markers (CA 125 and CA 19-9). In this report, we illustrated 3 patients with endometriosis who showed high values of CA 125 and 2 patients with dermoid cyst who showed high values of CA 19-9. It was impossible to rule out malignant disease in all cases preoperatively. In diagnosing ovarian tumors, bimanual examination, ultrasound, CT scan and tumor markers should all be considered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680806     DOI: 10.1159/000293559

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

1.  Squamous cell carcinoma arising in a mature cystic teratoma invading the sigmoid colon: a rare presentation.

Authors:  Alena Talia Gooneratne; Alexander Owen James; Jyoti Gupta; Yasser Abdulaal
Journal:  BMJ Case Rep       Date:  2015-05-02

2.  Markedly elevated CA19-9 associated with benign ovarian cyst and ascites.

Authors:  Oliver Brain; Laura H W Brown; Shaila Suvarna; Roger Chapman
Journal:  BMJ Case Rep       Date:  2009-03-20

3.  Endoscopic surgery for mature teratoma of the ovary.

Authors:  U Ulrich; J Keckstein; W Paulus; V Sasse
Journal:  Surg Endosc       Date:  1996-09       Impact factor: 4.584

4.  Risk factors for malignant transformation of mature cystic teratoma.

Authors:  Chan-Hong Park; Min-Hyung Jung; Yong-Il Ji
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

5.  Dermoid cyst with secretion of CA 19-9 detected by 18F-FDG PET/CT: A case report.

Authors:  Sheng-Che Lin; Ruoh-Fang Yen; Yen-Kung Chen
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.